Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement

Периоперационное ведение взрослых пациентов, принимающих агонисты рецепторов глюкагоноподобного пептида-1, агонисты рецепторов глюкозозависимого инсулинотропного полипептида и ингибиторы натрий-глюкозного котранспортёра 2-го типа: мультидисциплинарное консенсусное заключение
Dileep N. Lobo, Ketan Dhatariya, Dimitri J. Pournaras, Nicholas Levy, Kariem El‐Boghdadly, Jugdeep K. Dhesi, Philippa Fabb, Andrew McKechnie, Omar G. Mustafa, Philip Newland‐Jones, Anil Patel, Ken Clare, Anil Patel
2025-01-09

GIP receptor agonistsGLP-1 receptor agonistsSGLT2 inhibitorsperi-operative managementpulmonary aspiration
INTRODUCTION: Glucagon-like peptide-1 receptor agonists, dual glucose-dependent insulinotropic peptide receptor agonists and sodium-glucose cotransporter-2 inhibitors are used increasingly in patients receiving peri-operative care. These drugs may be associated with risks of peri-operative pulmonary aspiration or euglycaemic ketoacidosis. We produced a consensus statement for the peri-operative management of adults taking these drugs. METHODS: This multidisciplinary consensus statement included surgeons, anaesthetists, physicians, pharmacists and people with lived experience relevant to these guidelines. Following the directed literature review, a three-round modified Delphi process was conducted to generate and ratify recommendations. RESULTS: Patients taking glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic peptide receptor agonists should: continue these drugs before surgery; have full risk assessment and stratification; and receive peri-operative techniques that may mitigate risk of pulmonary aspiration before, during and after sedation or general anaesthesia. Patients taking sodium-glucose cotransporter-2 inhibitors should omit them the day before and the day of a procedure. All patients should have risks and mitigation strategies discussed with a shared decision-making approach. DISCUSSION: Until more evidence becomes available, this pragmatic, multidisciplinary consensus statement aims to support shared decision-making and improve safety for patients taking glucagon-like peptide-1 receptor agonists, dual glucose-dependent insulinotropic peptide receptor agonists and sodium-glucose cotransporter-2 inhibitors during the peri-operative period.
1
A multidisciplinary modified Delphi process produced consensus recommendations for peri-operative management of adults taking GLP-1, GIP, and SGLT2 drugs.
2
For GLP-1 and dual GIP agonist users, peri-operative techniques should be considered to mitigate pulmonary aspiration risk around sedation or general anaesthesia.
3
Management decisions should incorporate shared discussions of risks and mitigation strategies, acknowledging limited available evidence.
4
Patients taking GLP-1 receptor agonists or dual GIP receptor agonists should continue treatment before surgery after individualized risk assessment and stratification.
5
Patients taking SGLT2 inhibitors should omit these medications on the day before and the day of a procedure to reduce peri-operative risk of euglycaemic ketoacidosis.

Adults taking glucagon-like peptide-1 receptor agonists, dual glucose-dependent insulinotropic peptide receptor agonists, or sodium-glucose cotransporter-2 inhibitors during the peri-operative period

Peri-operative medication management, risk assessment, and mitigation of pulmonary aspiration and euglycaemic ketoacidosis

Publication Details
Publication Date
2025-01-09
Journal
Publisher
ISSN
Cited by
177
Access Type
Author Information
Authors
Dileep N. Lobo
Ketan Dhatariya
Dimitri J. Pournaras
Nicholas Levy
Kariem El‐Boghdadly
Jugdeep K. Dhesi
Philippa Fabb
Andrew McKechnie
Omar G. Mustafa
Philip Newland‐Jones
Anil Patel
Ken Clare
Anil Patel
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%